Biotech stocks 2024 outlook
<p>There have been many biotech breakthroughs over the past decade. Next come the regulatory approvals and the moneymaking products. One that caught my eye…</p>
<p>The first-ever gene-editing (CRISPR) therapy<strong> </strong>was just approved in the US and the UK.</p>
<p>CRISPR works like DNA scissors. It allows scientists to “delete” diseases from our bodies and “insert” healthy cells.</p>
<p>Victoria Gray is the first CRISPR patient to be treated for sickle cell — an incurable disease that causes bouts of excruciating pain.</p>
<p><a href="https://medium.com/@DisruptionHedge/biotech-stocks-2024-outlook-6f2b808ba3aa"><strong>Website</strong></a></p>